– UK, Manchester – Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is pleased to announce the appointment of Christopher Richards PhD as a Non-executive Director of the Company with effect from 11 November 2015. As part of his role, Christopher will chair the Nominations Committee and will also be a member of the Audit and Remuneration Committees.
Following a successful international career in the agrochemicals and life sciences industries, Christopher has become a highly experienced non-executive director and business adviser.
He currently holds a number of executive and non-executive roles at quoted and private businesses. He is the executive chairman of Plant Health Care plc (AIM: PHC) and a non-executive director of Dechra Pharmaceuticals plc (LSE: DPH) and of Origin Enterprises plc (AIM: OGN). He is also a non-executive director at Cibus Global Inc, a privately owned US biotechnology company, and the founder of Talestris Ltd, his consultancy business.
Christopher is the former chief executive officer of Arysta LifeScience, a Japan-based agrochemicals business which grew rapidly under his leadership. After stepping down as chief executive officer in 2009, he became Arysta LifeScience’s non-executive chairman until the sale of the business earlier this year to Platform Specialty Products.
Christopher began his executive career in 1983 at Imperial Chemical Industries plc in the crop science division, which became Syngenta. During 20 years, he lived in countries including Colombia and Japan in roles including Syngenta’s global product portfolio manager and marketing head for EMEA.
Anthony Clinch, Nanoco’s Chairman, said: “We are delighted to welcome Dr Christopher Richards to the Nanoco Board as a Non-executive Director. His wide ranging business experience, and particularly his experience in biotechnology and life sciences, will be invaluable as we drive the commercialisation of our technology in multiple target markets.”
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
